Insights on pharmacy innovation, healthcare technology, and patient care from the PlusVirtual team.
2 articles found tagged “FDA”
A drug approved by the FDA last month is not available in Canada. It might not be for another year. For patients with serious conditions, that wait is not an inconvenience. It is a crisis. Two regulatory changes announced in early 2026 could finally close that gap.
For more than 70 years, every antipsychotic medication on the market has worked by blocking dopamine receptors. That changed in September 2024 when the FDA approved Cobenfy, a combination of xanomelin